GlassScriptPhysician profile
Kenneth Finn
NPI 1669571634
$4,810.84
in general payments reported to CMS, 2019-2025
37 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $526 · 2021: $827 · 2022: $450 · 2023: $643 · 2024: $1,262 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,164 · Travel and Lodging: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,164.13 |
| Travel and Lodging | $213.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $732.78 | 2022-2025 | Eterna, Proclaim, Octrode |
| Collegium Pharmaceutical, INC. | $491.15 | 2019-2024 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $400.95 | 2023-2025 | Sprint Pns System |
| Biohaven Pharmaceuticals, INC. | $378.86 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $374.01 | 2019-2024 | Relistor |
| Boston Scientific Corporation | $292.96 | 2019-2025 | General - Pain Management |
| Abbvie INC. | $264.30 | 2022-2025 | |
| Saluda Medical Americas, INC. | $179.57 | 2024-2025 | Evoke |
| Pfizer INC. | $173.58 | 2019-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $164.69 | 2022 | |
| Scilex Pharmaceuticals INC. | $152.13 | 2021-2024 | Ztlido |
| Lilly USA, LLC | $124.69 | 2019-2021 | |
| Amgen INC. | $120.38 | 2021-2022 | |
| Merz North America, INC. | $99.67 | 2020 | |
| Medtronic, INC. | $86.51 | 2023-2024 | Intellis Adaptivestim |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $84.52 | 2021-2022 | |
| Mdd US Operations, LLC | $66.37 | 2019-2020 | |
| Nevro Corp. | $62.65 | 2019-2024 | Senza |
| Tersera Therapeutics LLC | $60.48 | 2024 | Prialt |
| Kaleo, INC. | $59.83 | 2019 | |
| Allergan, INC. | $43.83 | 2019-2020 | |
| Averitas Pharma INC. | $43.20 | 2024 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $42.79 | 2022-2023 | Seglentis |
| Redhill Biopharma INC. | $37.73 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $35.54 | 2019 | |
| Idorsia Pharmaceuticals US INC | $34.01 | 2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $29.53 | 2019 | |
| Spinal Simplicity, LLC | $24.28 | 2024 | Ha Minuteman G3-R |
| Stratus Medical, LLC | $22.82 | 2022 | |
| Bioventus LLC | $20.75 | 2024 | Durolane |
| Assertio Therapeutics, INC. | $19.27 | 2019 | |
| Ibsa Pharma INC. | $16.78 | 2024 | Tirosint, Licart |
| Saol Therapeutics INC. | $15.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.36 | 2019 | |
| Sentynl Therapeutics, INC. | $14.61 | 2019 | |
| Eisai INC. | $14.12 | 2021 | |
| Sonex Health, INC. | $10.76 | 2023 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Finn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.